2016年6月24-25日，临床肿瘤学新进展学术研讨会——Best of ASCO Event in China2016在杭州召开。24日上午的肝胆胰肿瘤专场上，中山大学附属肿瘤医院胃胰科外科邱海波对肝胆胰肿瘤的三个重要研究进行了评述。
三项研究摘要编号和题目：
Abstract 4003：Phase III randomized study ofsorafenib plus doxorubicin versus sorafenib in patients with advancedhepatocellular carcinoma (HCC)-CALGB 80802 (Alliance).
Abstract 4005：NETTER-1 Phase III: Efficacyand Safety Results in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate.
Abstract LBA4006：ESPAC-4: A multicenter,international, open label randomized controlled phase III trial of adjuvantcombination chemotherapy of gemcitabine (GEM) and capecitabine (CAP), versusmonotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma.
会议专题》》》2016临床肿瘤学新进展学术研讨会（BOA）
